Jay Bee Laminations Ltd H1 FY26 – ₹219 Cr Half-Year Sales, 32% Volume Growth, ROCE 32%: Transformer Cores, Expanding Ambitions, and a Balance Sheet That Lifts Weights
1. At a Glance – Blink and You’ll Miss the Punch
Jay Bee Laminations Ltd is that classic NSE-SME stock which looks calm on the surface but hides a full-blown industrial workout underneath. With a market cap of around ₹277 crore, a current price hovering near ₹123, and a six-month return that feels like falling down a staircase (-48.8%), the stock clearly hasn’t been winning popularity contests lately. Yet, under the hood, the company clocked ₹219 crore in half-year sales for Sep FY26, operates at a ROCE of 32%, and has expanded capacity aggressively from 11,700 MTPA to 18,060 MTPA. Debt to equity sits at a manageable 0.29, promoter holding is a steady 70.6%, and EPS for the latest half year stands at ₹1.64. This is not a sleepy laminations unit making metal confetti. This is a transformer-core specialist that wants to play in the 400 kV and 765 kV league while the stock market currently treats it like a benchwarmer. Curious why? Good. Keep reading.
2. Introduction – Old Company, New Ambitions, Moody Stock
Founded in 1988, Jay Bee Laminations Ltd is older than many of today’s retail investors. It has survived power cycles, steel cycles, regulatory cycles, and probably a few emotional cycles of its promoters too. For decades, the company has been in the unglamorous but essential business of CRGO silicon steel laminations—those precision-cut metallic layers that decide whether your transformer hums peacefully or screams like a stressed-out violin.
The company recently discontinued CRNGO silicon steel cores in H1 FY25, effectively saying, “Enough experimentation, let’s focus on what we do best.” That “best” is CRGO laminations for power and distribution transformers up to 220 kV, with an eye firmly locked on higher voltage segments by FY26.
The irony? While the business has been expanding capacity, customers, and geography, the stock price has been doing the opposite—shrinking, sulking, and testing investor patience. Quarterly profit volatility, rising working capital days, and SME-platform skepticism have not helped. But does that make the business weak—or just misunderstood? That’s the detective story we’re about to unpack.
3. Business Model – WTF Do They Even Do?
Imagine transformers as the heart of the power grid. Now imagine CRGO laminations as the arteries. Jay Bee Laminations doesn’t sell electricity, poles, or wires—it sells the metal brains that make transformers efficient.
The company manufactures:
Cut Laminations – precision-cut CRGO sheets tailored to transformer designs
Slit Coils – CRGO coils sliced into narrower formats
Assembled Cores – stacked laminations clamped into ready-to-install transformer cores
Revenue-wise, this is not a diversified buffet. Cut laminations alone contribute over 79% of product revenue. Distribution transformers account for 59% of segment revenue, power transformers 36%, and the rest is rounding error.
Manufacturing happens across three units in Noida and Greater Noida:
Unit I: 6,600 MTPA capacity, 2,458 MT produced in H2 FY25
Unit II: 11,460 MTPA capacity, 4,430 MT produced in H2 FY25, currently under expansion
Unit III: Planned 1,200 MTPA, trial runs done, commercial production expected May 2025
The business model is straightforward: import or procure CRGO steel, process it with tight tolerances, sell to transformer manufacturers. Margins depend on steel prices, efficiency, and volume utilization. No fancy IP, no SaaS-like margins—but high entry barriers due to quality, approvals, and client stickiness.
4. Financials Overview – Numbers That Argue With Each Other
Result Type Lock:Half Yearly Results Annualised EPS = Latest EPS × 2
Half-Year Financial Comparison (₹ crore)
Source table
Metric
Latest Half (Sep FY26)
Same Half Last Year
Previous Half
YoY %
HoH %
Revenue
219
153
214
43.1%
2.3%
EBITDA
10
23
20
-56.5%
-50.0%
PAT
4
14
11
-71.4%
-63.6%
EPS (₹)
1.64
6.39
4.86
-74.3%
-66.3%
Annualised EPS = ₹1.64 × 2 = ₹3.28
Commentary time. Revenue surged like it had espresso shots, but profits quietly left the party early. Margins compressed to 5%, interest stayed stubborn, and depreciation rose due to capacity expansion. Classic “growth pains” scenario—or classic “execution risk” warning? Which side are you on?
